Inoki, Yuta
Nishi, Kentaro
Osaka, Kei
Kaneda, Tomoya
Akiyama, Misaki
Sato, Mai
Ogura, Masao
Ide, Kentaro
Kamei, Koichi http://orcid.org/0000-0003-3528-6961
Article History
Received: 5 April 2023
Accepted: 29 September 2023
First Online: 25 October 2023
Declarations
:
: Koichi Kamei has received research funding from the Public Foundation of Vaccination Research Center, and the Taiju Life Social Welfare Foundation; donations from Chugai Pharmaceutical Co. Ltd., Teijin Pharma Ltd., Kyowa Kirin Co. Ltd., Shionogi & Co. Ltd., Daiichi Sankyo Co. Ltd., Mitsubishi Tanabe Pharma Co. Ltd, and Otsuka Pharmaceutical Co. Ltd.; and lecture fees from Terumo Co. Ltd., Baxter Ltd., and Zenyaku Kogyo Co., Ltd. Other authors have no potential conflicts of interests to disclose.
: The study was conducted according to the Helsinki Declaration’s principle and the Japanese Ministry of Health, Labor, and Welfare’s ethical guidelines. The study was approved by the Ethics Committee of the National Center for Child Health and Development (approval number: 2022-196).
: Informed consent was obtained from guardians of all patients in the study.